230 related articles for article (PubMed ID: 24270746)
1. Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome.
Mueller GC; Stierle L; Stark V; Steiner K; von Kodolitsch Y; Weil J; Mir TS
Heart; 2014 Feb; 100(3):214-8. PubMed ID: 24270746
[TBL] [Abstract][Full Text] [Related]
2. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC
Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647
[TBL] [Abstract][Full Text] [Related]
3. The effects of losartan versus beta-blockers on cardiovascular protection in marfan syndrome: A systematic review and meta-analysis.
Kang YN; Chi SC; Wu MH; Chiu HH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):182-190. PubMed ID: 31003918
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
Brooke BS; Habashi JP; Judge DP; Patel N; Loeys B; Dietz HC
N Engl J Med; 2008 Jun; 358(26):2787-95. PubMed ID: 18579813
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin Receptor Blockers vs. Beta-Blocker Therapy for Marfan Syndrome: A Systematic Review and Meta-Analysis.
Wang Z; Deng X; Kang X; Hu A
Ann Vasc Surg; 2022 May; 82():347-361. PubMed ID: 34998935
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin reduces Marfan aortic dilation.
McLoughlin D; McGuinness J; Byrne J; Terzo E; Huuskonen V; McAllister H; Black A; Kearney S; Kay E; Hill AD; Dietz HC; Redmond JM
Circulation; 2011 Sep; 124(11 Suppl):S168-73. PubMed ID: 21911808
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome.
Al-Abcha A; Saleh Y; Mujer M; Boumegouas M; Herzallah K; Charles L; Elkhatib L; Abdelkarim O; Kehdi M; Abela GS
Am J Cardiol; 2020 Aug; 128():101-106. PubMed ID: 32650901
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.
Mullen MJ; Flather MD; Jin XY; Newman WG; Erdem G; Gaze D; Valencia O; Banya W; Foley CE; Child A
Trials; 2013 Dec; 14():408. PubMed ID: 24289736
[TBL] [Abstract][Full Text] [Related]
10. The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers.
Möberg K; De Nobele S; Devos D; Goetghebeur E; Segers P; Trachet B; Vervaet C; Renard M; Coucke P; Loeys B; De Paepe A; De Backer J
Int J Cardiol; 2012 Jun; 157(3):354-8. PubMed ID: 21239069
[TBL] [Abstract][Full Text] [Related]
11. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.
Groenink M; den Hartog AW; Franken R; Radonic T; de Waard V; Timmermans J; Scholte AJ; van den Berg MP; Spijkerboer AM; Marquering HA; Zwinderman AH; Mulder BJ
Eur Heart J; 2013 Dec; 34(45):3491-500. PubMed ID: 23999449
[TBL] [Abstract][Full Text] [Related]
12. Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications.
Singh MN; Lacro RV
Can J Cardiol; 2016 Jan; 32(1):66-77. PubMed ID: 26724512
[TBL] [Abstract][Full Text] [Related]
13. Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome.
Selamet Tierney ES; Feingold B; Printz BF; Park SC; Graham D; Kleinman CS; Mahnke CB; Timchak DM; Neches WH; Gersony WM
J Pediatr; 2007 Jan; 150(1):77-82. PubMed ID: 17188619
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.
Pitcher A; Spata E; Emberson J; Davies K; Halls H; Holland L; Wilson K; Reith C; Child AH; Clayton T; Dodd M; Flather M; Jin XY; Sandor G; Groenink M; Mulder B; De Backer J; Evangelista A; Forteza A; Teixido-Turà G; Boileau C; Jondeau G; Milleron O; Lacro RV; Sleeper LA; Chiu HH; Wu MH; Neubauer S; Watkins H; Dietz H; Baigent C;
Lancet; 2022 Sep; 400(10355):822-831. PubMed ID: 36049495
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin receptor blockers for management of aortic root dilation associated with Marfan syndrome.
Loomba RS; Arora RR
Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1257-9. PubMed ID: 21985537
[No Abstract] [Full Text] [Related]
16. Marfan Sartan: a randomized, double-blind, placebo-controlled trial.
Milleron O; Arnoult F; Ropers J; Aegerter P; Detaint D; Delorme G; Attias D; Tubach F; Dupuis-Girod S; Plauchu H; Barthelet M; Sassolas F; Pangaud N; Naudion S; Thomas-Chabaneix J; Dulac Y; Edouard T; Wolf JE; Faivre L; Odent S; Basquin A; Habib G; Collignon P; Boileau C; Jondeau G
Eur Heart J; 2015 Aug; 36(32):2160-6. PubMed ID: 25935877
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.
Thakur V; Rankin KN; Hartling L; Mackie AS
Cardiol Young; 2013 Aug; 23(4):568-81. PubMed ID: 23083542
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic effect of angiotensin receptor blockers in children with genetic aortopathies: the early bird catches the worm.
Olfe J; Kanitz JJ; Stark VC; Stute F; von Kodolitsch Y; Biermann D; Huebler M; Kozlik-Feldmann R; Mir TS
Clin Res Cardiol; 2023 Nov; 112(11):1610-1619. PubMed ID: 37160466
[TBL] [Abstract][Full Text] [Related]
19. Relation of aortic root dilatation and age in Marfan's syndrome.
Aburawi EH; O'Sullivan J
Eur Heart J; 2007 Feb; 28(3):376-9. PubMed ID: 17208935
[TBL] [Abstract][Full Text] [Related]
20. Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome.
Ladouceur M; Fermanian C; Lupoglazoff JM; Edouard T; Dulac Y; Acar P; Magnier S; Jondeau G
Am J Cardiol; 2007 Feb; 99(3):406-9. PubMed ID: 17261408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
